Related Experiment Video
Updated: Aug 8, 2025
07:31
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
3.7K
KCNJ2/HIF1α positive-feedback loop promotes the metastasis of osteosarcoma
Mao Shen1, Runsang Pan2, Shan Lei2
1Department of Orthopedics, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550009, Guizhou, China.
Cell Communication and Signaling : CCS
|March 2, 2023
Summary
A positive feedback loop involving potassium inwardly rectifying channel subfamily J member 2 (KCNJ2) and HIF1α promotes osteosarcoma metastasis. Targeting this KCNJ2/HIF1α axis may offer new diagnostic and therapeutic strategies for osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Osteosarcoma (OS) is characterized by early metastasis.
- The role of potassium inwardly rectifying channel subfamily J member 2 (KCNJ2) in OS oncogenesis remains largely unknown.
- Members of the potassium inwardly rectifying channel family have demonstrated oncogenic roles in various cancers.
Discussion:
- KCNJ2 is overexpressed in advanced OS and correlates with poor patient survival.
- KCNJ2 inhibition reduces OS cell metastasis, while its elevation enhances it.
- A KCNJ2/HIF1α positive feedback loop significantly drives OS cell metastasis.
Key Insights:
- KCNJ2 directly binds to HIF1α, inhibiting its ubiquitination and increasing HIF1α expression.
- HIF1α binds to the KCNJ2 promoter, upregulating KCNJ2 transcription under hypoxia.
- This reciprocal regulation forms a positive feedback loop crucial for OS metastasis.
Outlook:
- The identified KCNJ2/HIF1α feedback loop presents a potential therapeutic target for osteosarcoma.
- Further research into this pathway could lead to novel diagnostic markers and treatment strategies for OS.
- Understanding this mechanism may pave the way for targeted therapies to inhibit osteosarcoma progression.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:07Cell Signaling Feedback Loops
6.4K
Positive and negative feedback loops are crucial for regulating biological signaling systems. These feedback loops are processes that connect output signals to their inputs.
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
6.4K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
02:30Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
01:24Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
01:22PI3K/mTOR/AKT Signaling Pathway
3.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.8K